VA5免疫增强剂对鸽新城疫病毒灭活疫苗的增效作用研究

doi:10.16431/j.cnki.1671-7236.2020.12.027

摘要/Abstract

摘要： 试验旨在探究VA5免疫增强剂对鸽新城疫病毒（NDV）灭活疫苗（ND4416株）的免疫增效作用。选取160只健康鸽随机分为4组：ND4416株灭活疫苗组（NDV组）、ND4416株灭活疫苗与免疫增强剂（VA5）混合组（NDV+VA5组）、La Sota灭活疫苗组（La Sota组）及生理盐水空白对照组（C组），进行免疫效力及免疫持续期试验。采用血凝抑制试验检测各组鸽免疫后不同时间点的血清抗体效价，结果显示，VA5免疫增强剂能够显著提高鸽NDV灭活疫苗血清抗体水平（P<0.05）。脾脏淋巴细胞转化试验结果显示，VA5能够有效刺激免疫鸽的淋巴细胞转化。在免疫后第30、90、180天，各组鸽子采用ND4416株进行攻毒试验，结果显示，NDV+VA5组在3个时间点的攻毒保护率均为100%，均高于La Sota组。免疫持续期试验结果显示，NDV+VA5组血清抗体水平在免疫后第21天达峰值11.20log₂，第180天仍能达到7.50log₂，攻毒保护率达100%，表明VA5免疫增强剂可延长鸽新城疫疫苗的免疫效力持续期至180 d。攻毒后体外排毒检测结果表明，VA5免疫增强剂能够缩短攻毒后鸽的体外排毒周期，减少体外排毒。综上，VA5免疫增强剂能够显著提高鸽NDV灭活疫苗的免疫效果，为研制效果更好的鸽NDV疫苗提供了基础依据，同时也为免疫增强剂的应用增加了试验数据。

关键词: 鸽; 新城疫病毒灭活疫苗; ND4416株; VA5免疫增强剂; 免疫效力

Abstract: This study was designed to evaluate the synergistic effect of VA5 immunopotentiator on pigeon ND4416 inactivated vaccine.160 healthy pigeons were randomly divided into four groups,including ND4416 strain inactivated vaccine group (NDV group),ND4416 strain inactivated vaccine and immunopotentiator (VA5) mixed group (NDV+VA5 group),La Sota inactivated vaccine group (La Sota group) and normal saline as the control group (C group),to assess their vaccine efficacy against virulent pigeon NDV by serological analysis and animal testing.Pigeons sera were collected at different time points after immunization and measured the HI antibody titer of each group.The results showed that VA5 immunopotentiator significantly improved the serum antibody level of pigeons immunized with pigeon Newcastle disease inactivated vaccine (P<0.05).In addition,comparative test of spleen lymphocyte transformation was conducted at various time points after immunization.The results indicated that VA5 effectively stimulated the lymphocyte transformation of immune pigeon.Pigeons in each groups were challenged with ND4416 strain at the 30th,90th and 180th d after immunization.The results presented that the NDV+VA5 group had 100% protection rate and higher than La Sota group.The duration of immunization test showed that the antibody titer of NDV+VA5 group reached peak 11.20log₂ at the 21st d,remained 7.50log₂ at 180th d,and the protection rate remained 100% at 180th d.It indicated that VA5 immunopotentiator sustained the immune duration of pigeon NDV vaccine up to 180 d.Moreover,the in vitro detoxification test results suggested that VA5 immunopotentiator reduced the in vitro detoxification cycle of pigeons after challenge.Overall,this study suggested VA5 immunopotentiator could significantly improve the immune efficacy of pigeon Newcastle disease inactivated vaccine,which provided a basis for further enhancing the efficacy of Newcastle disease vaccine,as well increased experimental data for the application of immunopotentiators.

Key words: pigeon; Newcastle disease virus inactivated vaccine; ND4416 strain; VA5 immunopotentiator; immune efficacy

中图分类号:

S852.65⁺9.5

熊晓妍, 覃振斌, 莫红芳, 何东贤, 虞霖田, 许家荣. VA5免疫增强剂对鸽新城疫病毒灭活疫苗的增效作用研究[J]. 中国畜牧兽医, 2020, 47(12): 4032-4040.

XIONG Xiaoyan, QIN Zhenbin, MO Hongfang, HE Dongxian, YU Lintian, XU Jiarong. Study on Synergistic Effect of VA5 Immunopotentiator on Pigeon NDV Inactivated Vaccine[J]. China Animal Husbandry and Veterinary Medicine, 2020, 47(12): 4032-4040.

参考文献

[1] ALEXANDER D J.Avian Paramyxoviridae——Recent developments[J].Veterinary Microbiology,1990,23(1):103-114.
[2] KALETA E F,ALEXANDER D J,RUSSELL P H.The first isolation of the avian PMV-1 virus responsible for the current panzootic in pigeons?[J].Avian Pathology,1985,14(4):553-557.
[3] MAYAHI M,SHAPOURI M R S A,JAFARI R A,et al.Characterization of isolated pigeon paramyxovirus-1(PMV-1) and its pathogenicity in broiler chickens[J].Veterinary Research Forum,2017,8(1):15-21.
[4] WANG J J,LIU H L,LIU W,et al.Genomic characterizations of six pigeon paramyxovirus type 1 viruses isolated from live bird markets in China during 2011 to 2013[J]. PLoS One,2015,10(4):e0124261.
[5] WANG X L,REN S H,WANG X W,et al.Genomic characterization of a wild-bird-origin pigeon paramyxovirus type 1(PPMV-1) first isolated in the Northwest region of China[J].Archives of Virology,2017,162(3):749-761.
[6] 罗瑶瑶,王静静,王云平,等.2014-2017年我国部分地区10株鸽副黏病毒的分布及其分子特征[J].中国兽医学报,2018,262(10):1883-1886. LUO Y Y,WANG J J,WANG Y P,et al.Distribution and molecular characteristics of 10 pigeon paramyxovirus typeⅠ isolates in some regions of China during 2014 to 2017[J].Chinese Journal of Veterinary Science,2018,262(10):1883-1886.(in Chinese)
[7] AWU A,SHAO M Y,LIU M M,et al.Characterization of two pigeon paramyxovirus type 1 isolates in China[J].Avian Pathology,2015,44(3):204-211.
[8] GUO H B,LIU X L,HAN Z X,et al.Phylogenetic analysis and comparison of eight strains of pigeon paramyxovirus type 1(PPMV-1) isolated in China between 2010 and 2012[J].Archives of Virology,2013,158(6):1121-1131.
[9] 王林,韦海涛,宋彦军,等.鸽新城疫病毒北京分离株F基因的遗传进化分析[J].动物医学进展,2015,36(2):48-52. WANG L,WEI H T,SONG Y J,et al.Genetic evolution analysis of F gene of a Newcastle disease virus isolate from pigeon in Beijing[J].Progress in Veterinary Medicine,2015,36(2):48-52.(in Chinese)
[10] QIU X S,MENG C C,ZHAN Y,et al.Phylogenetic,antigenic and biological characterization of pigeon paramyxovirus type 1 circulating in China[J].Virology Journal,2017,14(1):186-199.
[11] 赵宝华,傅元华,范建华,等.鸽新城疫油乳剂灭活疫苗的研制[J].江苏农业学报,2010,26(6):1293-1297. ZHAO B H,FU Y H,FAN J H,et al.Development of bivalent inactivated oil-emulsion vaccine against pigeon paramyxovirus disease[J].Jiangsu Journal of Agricultural Sciences,2010,26(6):1293-1297.(in Chinese)
[12] 李珮瑶,高晶萍,田勇,等.鸽新城疫HB株水佐剂灭活疫苗的制备及免疫特性[J].河南农业科学,2019,48(9):143-147. LI P Y,GAO J P,TIAN Y,et al.Preparation and immunological characteristics of water adjuvant inactivated vaccine of pigeon Newcastle disease HB strain[J].Journal of Henan Agricultural Sciences,2019,48(9):143-147.
[13] MALLICK A I,PARVIZI P,READ L R,et al.Enhancement of immunogenicity of a virosome-based avian influenza vaccine in chickens by incorporating CpG-ODN[J].Vaccine,2011,29(8):1657-1665.
[14] 陆吉虎,吴培培,张雪花,等.免疫增强剂提高H9亚型禽流感灭活疫苗在SPF鸡体中细胞因子的免疫应答[J].江苏农业学报,2016,32(2):408-413. LU J H,WU P P,ZHANG X H,et al.Immunopotentiators improving the cytokine immune response to inactivated H9 subtype avian influenza vaccine in SPF chickens[J].Jiangsu Journal of Agricultural Sciences,2016,32(2):408-413.(in Chinese)
[15] 唐应华,陆吉虎,吴培培,等.免疫增强剂对禽流感疫苗免疫持续期、安全性和鸡淋巴细胞转化的影响[J].江苏农业学报,2014,30(4):821-825. TANG Y H,LU J H,W P P,et al.Influence of immunopotentiator on antibody persistence period,avian influenza vaccine safety and chicken lymphocyte transformation efficiency[J].Jiangsu Journal of Agricultural Sciences,2014,30(4):821-825.(in Chinese)
[16] GUO H B,LIU X L,XU Y,et al.A comparative study of pigeons and chickens experimentally infected with PPMV-1 to determine antigenic relationships between PPMV-1 and NDV strains[J].Veterinary Microbiology,2014,168(1):88-97.
[17] ALDOUS E W,MYNN J K,IRVINE R M,et al.A molecular epidemiological investigation of avian paramyxovirus type 1 viruses isolated from game birds of the order Galliformes[J]. Avian Pathology,2010,39(6):519-524.
[18] REN S H,WANG C Y,ZHANG X Z,et al,Phylogenetic and pathogenic characterization of a pigeon paramyxovirus type 1 isolate reveals cross-species transmission and potential outbreak risks in the Northwest region of China[J].Archives of Virology,2017,162(9):2755-2767.
[19] 贺奋义.鸽新城疫的研究概况[J].国外畜牧学:猪与禽,2013,33(6):73-76. HE F Y.Research overview of pigeon Newcastle disease[J].Animal Science Abroad-Pigs and Poultry,2013,33(6):73-76.(in Chinese)
[20] 熊晓妍,孙兴臣,李敏婕,等.赛鸽新城疫病毒南京分离株的生物学特性及其F和HN基因的分析[J].中国兽医科学,2017,47(11):1363-1370. XIONG X Y,SUN X C,LI M J,et al.Biologic characterization and F and HN gene analysis of racing pigeon Newcastle disease virus strain from Nanjing[J].Chinese Veterinary Science,2017,47(11):1363-1370.(in Chinese)
[21] 张俊平,杨惠萍,邹勇,等.鸽副黏病毒Ⅰ型灭活疫苗(S-1株)与鸡新城疫灭活疫苗对比试验[J].上海畜牧兽医通讯,2009,23(4):23. ZHANG J P,YANG H P,ZOU Y,et al.Comparative test of inactivated pigeon paramyxovirus type 1(S-1 strain) and inactivated chicken Newcastle disease vaccine[J].Shanghai Journal of Animal Husbandry and Veterinary Medicine,2009,23(4):23.(in Chinese)
[22] KIM L M,KING D J,GUZMAN H,et al.Biological and phylogenetic characterization of pigeon paramyxovirus serotype 1 circulating in wild North American pigeons and doves[J].Journal of Clinical Microbiology,2008,46(10):3303-3310.